Table 1. The demographic, clinical, and MR image data of control and patient groups.
Characteristic | Group | ||
---|---|---|---|
Controls (N = 50) | SCA3 Patients (N = 48) | p value | |
Sex(F/M) | 25/25 | 21/27 | 0.535 a |
Age(years) † | 48.24 ± 13.956 | 48.13 ± 11.747 | 0.516 b |
Duration(years) † | — | 8.89 ± 6.432 | — |
SARA † | — | 14 ± 8.103 | — |
H & Y staging † | — | 2.88 ± 1.19 | — |
MMSE † | — | 28.5 ± 1.61 | — |
EEG signals observation(abnormal/normal) | — | 5/12 | — |
Cerebral atrophy observed via visual inspection | — | 9 | — |
Cerebellar atrophy observed via visual inspection | — | 39 | — |
SARA = Scale for the Assessment and Rating of Ataxia; MMSE = Mini-Mental State Examination; H & Y staging = Hoehn and Yahr Staging Scale
a Pearson's chi square test(χ 2 = 0.384);
b two-tailed two-sample t-test;
† Continuous variables are expressed as mean ± standard deviation (SD);